Measures to accelerate Ayushman Bharat Health Account (ABHA) adoption in the country
An individual can create their Ayushman Bharat Health Account (number) (ABHA) which is a unique identifier for a citizen in the health ecosystem. Presently, ABHA can be created by an individual through their Aadhaar number or driving license. ABHA will help the individual to link and share their digital health records with consent across multiple […]
Steps taken under Anaemia Mukt Bharat (AMB) strategy
The Government of India implements Anaemia Mukt Bharat (AMB) strategy under POSHAN Abhiyaan with the target for reducing anaemia in the six population groups - Children (6-59 months), Children (5-9 years), Adolescents girls and boys (10-19 years), Pregnant women, Lactating women and Women of Reproductive Age (WRA) group (15-49 years) in life cycle approach. Some […]
Measures to tackle Black Marketing of Blood
It is primarily the responsibility of the State/UT Government to take concrete steps to prevent illegal activities taking place in blood banks and during blood transfusion. Government has made registration of blood banks mandatory as per the provisions of Drugs and Cosmetic Act and Rules thereunder. Further, Government has notified Drugs and Cosmetics (Second Amendment) […]
Anti-fraud system for India’s National Health Insurance Scheme (AB-PMJAY)
Ayushman Bharat –Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) is governed on a zero-tolerance approach to any kind of fraud viz. suspect/non-genuine medical treatment claims, impersonation and up-coding of treatment packages/procedures etc. The Government of India adopts a pro-active approach towards fraud and abuse. It goes on to underscore that several countervailing strategies have been employed […]
Pharma companies manufacturing generic medicine
The manufacturing licenses for generic drugs and new drugs are granted by the various State Drug Controllers and the Drug Controller General of India (under Ministry of Health and Family Welfare) respectively. A common list of all such manufacturers of generic drugs in the private sector is not maintained in the Department of Pharmaceuticals. However, […]
Import and domestic production of APIs
The Indian Pharmaceutical industry is the 3rd largest in the world by volume. India is one of the major producers of Active Pharma Ingredients (API) or bulk drugs in the world. India exported Bulk Drugs/Drug Intermediates worth Rs. 33,320 crore in financial year 2021-22. However, the country also imports various Bulk Drugs/APIs for producing medicines […]
Proposal to send specialist doctors to rural areas
As per the District Residency Program notified by the Board of Governors, all the post graduate students pursuing MD/MS in broad specialties in all Medical Colleges/Institutes under the Indian Medical Council Act, 1956 shall undergo a compulsory residential rotation of three months in District Hospitals/ District Health System as a part of the course curriculum. […]
Pharmaceutical Industry in Maharashtra
The Department has recently issued the guidelines of the scheme “Strengthening of Pharmaceutical Industry (SPI) on 11th March 2022. The scheme is applicable to all parts of the country. The objectives of the scheme are as follows: To strengthen the existing infrastructure facilities in order to make India a global leader in the Pharma Sector […]
WHO launches appeal to respond to urgent health needs in the greater Horn of Africa
Millions of lives are in peril, including children. US$ 123.7 million is needed for the health agency’s response until December 2022. Geneva/Nairobi, 2 August 2022 | The health and lives of people in the greater Horn of Africa are threatened as the region faces an unprecedented food crisis. In order to carry out urgent, life-saving […]
Roche’s subcutaneous formulation of Tecentriq demonstrates positive Phase III results
IMscin001 study showed non-inferior levels of cancer immunotherapy Tecentriq in the blood, when injected subcutaneously, compared to intravenous infusion, in people with advanced non-small cell lung cancer Administered under the skin, the subcutaneous formulation reduces time spent receiving treatment to just minutes, compared with up to an hour for IV infusion Data will be submitted […]
